Literature DB >> 30102262

Body Parts Matter: Social, Behavioral, and Biological Considerations for Urethral, Pharyngeal, and Rectal Gonorrhea and Chlamydia Screening Among MSM in Lima, Peru.

Ryan Colby Passaro1,2, Eddy R Segura2,3, Amaya Perez-Brumer4, Jeanne Cabeza2, Silvia M Montano5, Jordan E Lake2,6, Jorge Sanchez7,8,9, Javier R Lama7,9, Jesse L Clark2.   

Abstract

BACKGROUND: Gonorrhea (Neisseria gonorrhoeae [GC]) and chlamydia (Chlamydia trachomatis [CT]) disproportionately affect men who have sex with men (MSM), and public health implications vary by anatomic site and bacterial agent. Urethral and rectal GC and CT can increase risk of HIV transmission, whereas pharyngeal GC may be a reservoir for antimicrobial resistance. To define screening priorities in Latin America, we compare differences in the prevalence and correlates of urethral, pharyngeal, and rectal GC and CT among MSM in Peru.
METHODS: A cross-sectional sample of 787 MSM from Lima was screened between 2012 and 2014. We described prevalence of urethral, pharyngeal, and rectal GC and CT infection and conducted bivariate analyses of associations with social, behavioral, and biological characteristics. Poisson regression analyses assessed the correlates of each infection at each anatomic site.
RESULTS: The most commonly symptomatic infection (urethral GC; 42.1%) was the least prevalent (2.4%). The most prevalent infections were rectal CT (15.8%) and pharyngeal GC (9.9%). Rectal CT was the least commonly symptomatic (2.4%) infection, and was associated with younger age (adjusted prevalence ratio [95% confidence interval], 0.96 [0.94-0.98]), HIV infection (1.46 [1.06-2.02]), and pasivo (receptive; 3.59 [1.62-7.95]) and moderno (versatile; 2.63 [1.23-5.60]) sexual roles.
CONCLUSIONS: Results highlight limitations of current syndromic screening strategies for sexually transmitted diseases in Peru, wherein urethral CT and rectal GC and CT may be missed due to their frequently asymptomatic presentations. Successful management of GC and CT infections among MSM in low-resource settings requires differentiating between bacterial agent, symptomatic presentation, associated risk factors, and public health implications of untreated infection at different anatomic sites.

Entities:  

Mesh:

Year:  2018        PMID: 30102262      PMCID: PMC6092933          DOI: 10.1097/OLQ.0000000000000816

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  26 in total

1.  Infections missed by urethral-only screening for chlamydia or gonorrhea detection among men who have sex with men.

Authors:  Julia L Marcus; Kyle T Bernstein; Robert P Kohn; Sally Liska; Susan S Philip
Journal:  Sex Transm Dis       Date:  2011-10       Impact factor: 2.830

2.  Prevalence and incidence of pharyngeal gonorrhea in a longitudinal sample of men who have sex with men: the EXPLORE study.

Authors:  Sheldon R Morris; Jeffrey D Klausner; Susan P Buchbinder; Sarah L Wheeler; Beryl Koblin; Thomas Coates; Margaret Chesney; Grant N Colfax
Journal:  Clin Infect Dis       Date:  2006-10-10       Impact factor: 9.079

3.  Moderno love: sexual role-based identities and HIV/STI prevention among men who have sex with men in Lima, Peru.

Authors:  Jesse Clark; Javier Salvatierra; Eddy Segura; Ximena Salazar; Kelika Konda; Amaya Perez-Brumer; Eric Hall; Jeffrey Klausner; Carlos Caceres; Thomas Coates
Journal:  AIDS Behav       Date:  2013-05

4.  The effects of urethritis on seminal plasma HIV-1 RNA loads in homosexual men not receiving antiretroviral therapy.

Authors:  S T Sadiq; S Taylor; A J Copas; J Bennett; S Kaye; S M Drake; S Kirk; D Pillay; I V D Weller
Journal:  Sex Transm Infect       Date:  2005-04       Impact factor: 3.519

5.  Prevalence of rectal, urethral, and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California, 2003.

Authors:  Charlotte K Kent; Janice K Chaw; William Wong; Sally Liska; Steven Gibson; Gregory Hubbard; Jeffrey D Klausner
Journal:  Clin Infect Dis       Date:  2005-05-26       Impact factor: 9.079

6.  HIV Incidence Among Men Who Have Sex With Men After Diagnosis With Sexually Transmitted Infections.

Authors:  David A Katz; Julia C Dombrowski; Teal R Bell; Roxanne P Kerani; Matthew R Golden
Journal:  Sex Transm Dis       Date:  2016-04       Impact factor: 2.830

7.  Frequent Transmission of Gonorrhea in Men Who Have Sex with Men.

Authors:  Christopher K Fairley; Jane S Hocking; Lei Zhang; Eric P F Chow
Journal:  Emerg Infect Dis       Date:  2017-01       Impact factor: 6.883

8.  Syndromic management and STI control in urban Peru.

Authors:  Jesse L Clark; Andres G Lescano; Kelika A Konda; Segundo R Leon; Franca R Jones; Jeffrey D Klausner; Thomas J Coates; Carlos F Caceres
Journal:  PLoS One       Date:  2009-09-25       Impact factor: 3.240

9.  Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio.

Authors:  Aluísio J D Barros; Vânia N Hirakata
Journal:  BMC Med Res Methodol       Date:  2003-10-20       Impact factor: 4.615

10.  High prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae infections in anal and pharyngeal sites among a community-based sample of men who have sex with men and transgender women in Lima, Peru.

Authors:  Segundo R Leon; Eddy R Segura; Kelika A Konda; Juan A Flores; Alfonso Silva-Santisteban; Jerome T Galea; Thomas J Coates; Jeffrey D Klausner; Carlos F Caceres
Journal:  BMJ Open       Date:  2016-01-06       Impact factor: 2.692

View more
  6 in total

1.  Sexual network characteristics of men who have sex with men with syphilis and/or gonorrhoea/chlamydia in Lima, Peru: network patterns as roadmaps for STI prevention interventions.

Authors:  Cherie Blair; Ryan Colby Passaro; Eddy R Segura; Jordan E Lake; Amaya G Perez-Brumer; Jorge Sanchez; Javier R Lama; Jesse L Clark
Journal:  Sex Transm Infect       Date:  2019-04-22       Impact factor: 3.519

2.  Optimizing Screening for Anorectal, Pharyngeal, and Urogenital Chlamydia trachomatis and Neisseria gonorrhoeae Infections in At-Risk Adolescents and Young Adults in New Orleans, Louisiana and Los Angeles, California, United States.

Authors:  Olivia M Man; Wilson E Ramos; Gabriella Vavala; Cameron Goldbeck; Manuel A Ocasio; Jasmine Fournier; Adriana Romero-Espinoza; M Isabel Fernandez; Dallas Swendeman; Sung-Jae Lee; Scott Comulada; Mary Jane Rotheram-Borus; Jeffrey D Klausner
Journal:  Clin Infect Dis       Date:  2021-11-02       Impact factor: 9.079

3.  Prevalence of bacterial sexually transmitted infections and coinfection with HIV among men who have sex with men and transgender women in Tijuana, Mexico.

Authors:  Claire C Bristow; Cristina Espinosa da Silva; Alicia H Vera; Jesus E Gonzalez-Fagoaga; Gudelia Rangel; Heather A Pines
Journal:  Int J STD AIDS       Date:  2021-02-03       Impact factor: 1.456

Review 4.  The role of saliva in gonorrhoea and chlamydia transmission to extragenital sites among men who have sex with men: new insights into transmission.

Authors:  Eric Pf Chow; Christopher K Fairley
Journal:  J Int AIDS Soc       Date:  2019-08       Impact factor: 5.396

Review 5.  Controversies and evidence on Chlamydia testing and treatment in asymptomatic women and men who have sex with men: a narrative review.

Authors:  Nicole H T M Dukers-Muijrers; Ymke J Evers; Christian J P A Hoebe; Petra F G Wolffs; Henry J C de Vries; Bernice Hoenderboom; Marianne A B van der Sande; Janneke Heijne; Jeffrey D Klausner; Jane S Hocking; Jan van Bergen
Journal:  BMC Infect Dis       Date:  2022-03-14       Impact factor: 3.090

6.  Contextualizing condoms: a cross-sectional study mapping intersections of locations of sexual contact, partner type, and substance use as contexts for sexual risk behavior among MSM in Peru.

Authors:  R Colby Passaro; Angelica Castañeda-Huaripata; Williams Gonzales-Saavedra; Susan Chavez-Gomez; Eddy R Segura; Jordan E Lake; Robinson Cabello; Jesse L Clark
Journal:  BMC Infect Dis       Date:  2019-11-11       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.